{"id":3181,"date":"2024-03-10T21:33:42","date_gmt":"2024-03-10T20:33:42","guid":{"rendered":"https:\/\/solmed-clinic.com\/?post_type=ispitivanja&p=3181"},"modified":"2024-07-01T20:45:50","modified_gmt":"2024-07-01T18:45:50","slug":"ulcerative-colitis-il-1-study","status":"publish","type":"ispitivanja","link":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/","title":{"rendered":"Ulcerative Colitis (IL-1 Study)"},"content":{"rendered":"

Location: Solmed Polyclinic (Zagreb), SB Medico (Rijeka)<\/h3>\n

Study Drug:<\/strong> Patients will receive either standard biological therapy (adalimumab) or experimental biological therapy with an IL-1 proinflammatory molecule blocker.<\/p>\n

Main Inclusion Criteria:<\/strong> Patients aged 18 and older with an official diagnosis of ulcerative colitis who, with at least one previous line of treatment (either conventional or biological therapy), have symptoms of active disease. Previous biological therapy must not include only adalimumab; all other drugs are allowed.<\/p>\n

Status: Soon enrolling patients<\/span><\/h3>\n
\n
\n
\n

Start of patient enrollment: August 2024.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Study Drug: Patients will receive either standard biological therapy (adalimumab) or experimental biological therapy with an IL-1 proinflammatory molecule blocker.<\/p>\n","protected":false},"featured_media":0,"template":"","status_ispitivanja":[81],"podrucja":[116],"class_list":["post-3181","ispitivanja","type-ispitivanja","status-publish","hentry","status_ispitivanja-includes-patients","podrucja-gastroenterology"],"acf":[],"yoast_head":"\nUlcerative Colitis (IL-1 Study) - Solmed Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ulcerative Colitis (IL-1 Study) - Solmed Clinic\" \/>\n<meta property=\"og:description\" content=\"Study Drug: Patients will receive either standard biological therapy (adalimumab) or experimental biological therapy with an IL-1 proinflammatory molecule blocker.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Solmed Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/solmedgrupa\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-01T18:45:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/en\\\/ispitivanja\\\/ulcerative-colitis-il-1-study\\\/\",\"url\":\"https:\\\/\\\/solmed-clinic.com\\\/en\\\/ispitivanja\\\/ulcerative-colitis-il-1-study\\\/\",\"name\":\"Ulcerative Colitis (IL-1 Study) - Solmed Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/#website\"},\"datePublished\":\"2024-03-10T20:33:42+00:00\",\"dateModified\":\"2024-07-01T18:45:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/en\\\/ispitivanja\\\/ulcerative-colitis-il-1-study\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/solmed-clinic.com\\\/en\\\/ispitivanja\\\/ulcerative-colitis-il-1-study\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/en\\\/ispitivanja\\\/ulcerative-colitis-il-1-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna stranica\",\"item\":\"https:\\\/\\\/solmed-clinic.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ulcerative Colitis (IL-1 Study)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/#website\",\"url\":\"https:\\\/\\\/solmed-clinic.com\\\/\",\"name\":\"Solmed Clinic\",\"description\":\"Solutions in medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/solmed-clinic.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/#organization\",\"name\":\"Solmed Clinic\",\"url\":\"https:\\\/\\\/solmed-clinic.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/solmed-clinic.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/solmed-small.svg\",\"contentUrl\":\"https:\\\/\\\/solmed-clinic.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/solmed-small.svg\",\"width\":482,\"height\":77,\"caption\":\"Solmed Clinic\"},\"image\":{\"@id\":\"https:\\\/\\\/solmed-clinic.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/solmedgrupa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ulcerative Colitis (IL-1 Study) - Solmed Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/","og_locale":"en_US","og_type":"article","og_title":"Ulcerative Colitis (IL-1 Study) - Solmed Clinic","og_description":"Study Drug: Patients will receive either standard biological therapy (adalimumab) or experimental biological therapy with an IL-1 proinflammatory molecule blocker.","og_url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/","og_site_name":"Solmed Clinic","article_publisher":"https:\/\/www.facebook.com\/solmedgrupa","article_modified_time":"2024-07-01T18:45:50+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/","url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/","name":"Ulcerative Colitis (IL-1 Study) - Solmed Clinic","isPartOf":{"@id":"https:\/\/solmed-clinic.com\/#website"},"datePublished":"2024-03-10T20:33:42+00:00","dateModified":"2024-07-01T18:45:50+00:00","breadcrumb":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-il-1-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna stranica","item":"https:\/\/solmed-clinic.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ulcerative Colitis (IL-1 Study)"}]},{"@type":"WebSite","@id":"https:\/\/solmed-clinic.com\/#website","url":"https:\/\/solmed-clinic.com\/","name":"Solmed Clinic","description":"Solutions in medicine","publisher":{"@id":"https:\/\/solmed-clinic.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/solmed-clinic.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/solmed-clinic.com\/#organization","name":"Solmed Clinic","url":"https:\/\/solmed-clinic.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/","url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","contentUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","width":482,"height":77,"caption":"Solmed Clinic"},"image":{"@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/solmedgrupa"]}]}},"_links":{"self":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/3181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja"}],"about":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/types\/ispitivanja"}],"version-history":[{"count":4,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/3181\/revisions"}],"predecessor-version":[{"id":3873,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/3181\/revisions\/3873"}],"wp:attachment":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/media?parent=3181"}],"wp:term":[{"taxonomy":"status_ispitivanja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/status_ispitivanja?post=3181"},{"taxonomy":"podrucja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/podrucja?post=3181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}